Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

192.25
Delayed Data
As of Dec 09
 +3.78 / +2.01%
Today’s Change
184.50
Today|||52-Week Range
317.48
-38.48%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Operating ActivitiesNet Income / Starting Line-629.3M256.4M-499.9M15.2B
 
 
 
 
 
Depreciation1.6B1.6B1.7B1.6B
 
 
 
 
 
Total Other Cash Flow696.5M204.8M429.3M-18.2B
 
 
 
 
 
Funds From Operations1.8B1.6B1.8B-1.6B
 
 
 
 
 
Funds From/For Other Operating Expenses219.2M357.7M402.4M-459.8M
 
 
 
 
 
Net Cash Flow - Operating Activities1.6B1.2B1.4B-1.1B
 
 
 
 
 
 
InvestingIncrease In Investments2.7M0.000.00-15.4B
 
 
 
Decrease In Investments883.0M19.0M6.5M--
 
 
 
 
Capital Expenditures-104.2M-84.9M-97.9M-67.7M
 
 
 
 
 
Fixed Asset Disposal6.5M12.1M2.4M33.3B
 
 
 
 
 
Net Assets From Acquisitions -2.3B0.000.00-74.5M
 
 
 
Other Investing - Sources--0.000.0040.0M
 
 
Net Cash Flow Investing-2.4B-53.8M-89.0M17.8B
 
 
 
 
 
 
FinancingShort Term Borrowings----------
Long Term Borrowings799.3M900.0M0.00150.0M
 
 
 
 
Long Term Debt Reduction-807.5M-854.2M-3.0B-7.0B
 
 
 
 
 
Net Proceeds Stock Sale34.2M69.6M37.7M30.7M
 
 
 
 
 
Common Preferred Redeemed-9.8M-53.2M-14.1M-2.7B
 
 
 
 
 
Common Dividends----------
Cash Dividends Paid - Total-69.7M-69.6M-69.6M-69.6M
 
 
 
 
 
Other Sources - Financing22.1M34.6M-2.7M-5.3M
 
 
 
 
 
Other Uses - Financing91.8M32.3M31.5M13.9M
 
 
 
 
 
Net Cash Flow - Financing-123.2M-5.1M-3.1B-9.6B
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-1.4M5.2M-3.2M2.3M
 
 
 
 
 
 
Net Change In Cash-966.5M1.2B-1.8B7.1B